Skip to main content

EULAV Asset Management

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1540826 SARASOTA, FL

Position in VRTX

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$9,686,235
+$308,895 QoQ
Shares Held
19,500
-7.1% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#376
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

EULAV Asset Management holds $79,502,134 across 4 Biotechnology names. VRTX ranks #4 (12.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 VRTX
Vertex Pharmaceuticals Inc / Ma
This page
19,500 $9,686,235

All Filings in VRTX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,686,235 19,500
2026-03-31 $9,377,340 21,000
2025-12-31 $9,973,920 22,000
2025-09-30 $8,616,080 22,000
2025-06-30 $10,106,040 22,700
2025-03-31 $13,817,370 28,500
2024-12-31 $11,476,950 28,500
2024-09-30 $14,650,020 31,500
2024-06-30 $16,873,920 36,000
2024-03-31 $15,842,579 37,900
2023-12-31 $15,624,576 38,400
2023-09-30 $11,614,516 33,400
2023-06-30 $12,492,805 35,500
2023-03-31 $11,815,125 37,500
2022-12-31 $12,128,760 42,000
2022-09-30 $13,900,815 48,010
2022-06-30 $15,218,914 54,008
2022-03-31 $15,660,026 60,007
2021-12-31 $17,568,000 80,000
2021-09-30 $19,590,120 108,000
2021-06-30 $28,631,460 142,000
2021-03-31 $32,233,500 150,000
2020-12-31 $18,434,520 78,000
2020-09-30 $12,653,580 46,500
2020-06-30 $13,505,221 46,520
2020-03-31 $12,135,450 51,000